Viewing Study NCT04024761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:47 AM
Ignite Modification Date: 2026-01-28 @ 1:59 PM
Study NCT ID: NCT04024761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-12
First Post: 2019-07-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Myelodysplastic Syndromes View
None Myeloproliferative Neoplasm View
None Juvenile Myelomonocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View